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SEVERAL cellular processes are regulated by interfacial
catalysis on biomembrane surfaces. Phospholipases A2
(PLA2) are interesting not only as prototypes for interfacial
catalysis, but also because they mobilize precursors for the
biosynthesis of eicosanoids and platelet activating factor,
and these agents ultimately control a wide range of secre-
tory and inflammatory processes. Since PLA2 carry out
their catalytic function at membrane surfaces, the kinetics
of these enzymes depends on what the enzyme ’sees’ at
the interface, and thus the observed rate is profoundly
influenced by the organization and dynamics of the lipid-
water interface (’quality of the interface’). In this review
we elaborate the advantages of monitoring interfacial cata-
lysis in the scooting mode, that is, under the conditions
where the enzyme remains bound to vesicles for several
thousand catalytic turnover cycles. Such a highly pro-
cessive catalytic turnover in the scooting mode is useful
for a rigorous and quantitative characterization of the
kinetics of interfacial catalysis. This analysis is now ex-
tended to provide insights into designing strategy for
PLA2 assays and screens for their inhibitors.
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Introduction
Interfacial catalysis is an intriguing biophysical
phenomenon because it involves a complex
interplay of physical and biochemical processes.
Recently it has attracted considerable attention as
such processes are implicated in signal transduction
and other cellular regulatory mechanisms in which
water-soluble proteins are forced to act on the
substrate localized in biomembranes. Several classes
of proteins are known to be functionally active at
interfaces; for example, lipolytic enzymes, protein
and acylglycerol kinases, acyltransferases and
certain glycosidases. Interfacial catalysis by lipolytic
enzymes is involved in diverse processes such as the
digestion of fats, the tailoring of membrane lipids,
digestion of phagocytosed bacteria, and the
modulation of signal transduction. 1’2 A resurgence
of interest in PLA2 has been sparked by the
Abbreviations: DMPC, dimyristoyl glycero-sn-3-phosphocholine;
DMPM, dimyristoyl glycero-sn-3-phosphomethanol; DTPC, ditetra-
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possibility that the release of arachidonate and
lysophospholipids from membrane phospholipids is
probably the rate-limiting step in the biosynthesis of
eicosanoids (prostaglandins, thromboxanes, leuko-
trienes, lipoxins, hydroxyeicosatetraenoic acids) and
may be involved in the generation of the precursor
for platelet activating factor. These regulatory
molecules ultimately control a wide range of
physiological and pathological processes leading to
inflammation, rheumatoid arthritis, asthma, ischae-




By definition, PLA. hydrolyse the sn-2-ester
bond in 1,2-diacylglycero-sn-3-phospholipids. Two
classes of soluble PLA2 have been adequately
characterized, secretory and cytoplasmic PLA2.
Secretory PEA e: Secretory phospholipases A2 are
ubiquitous in secretory granules of inflammatory
cells and in extracellular exudates (pancreatic,
ascitis, synovial and peritoneal), and venoms
(snakes, bees, or lizards). Their molecular and
catalytic properties are similar, which suggests a
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role for these enzymes in digestion and defence
mechanisms, including macrophage functions. The
genes coding for type I PLA2 (in pancreas, spleen,
gastric mucosa, lung, stomach, kidney, and elapid
snakes of the Old World) and type II PLA2 (in
venoms of crotalids and viperids of the New World,
platelets, macrophages, ascites, neutrophils, pla-
centa, tonsil, kidney, synovial fluid and liver
mitochondria) are localized on chromosomes 12 and
1, respectively.
3 These stable and water-soluble
enzymes contain about 120 amino acids in a highly
conserved single polypeptide chain with a rigid
three-dimensional structure stabilized by seven
disulphide bridges.
4,s
The two types of PLA2 are distinguished by the
translocation of Cys from positions 11 and 77 in
type I, to 50 and 132 in,type II, which also contains
seven additional amino acid residues at the
C-terminus. Calcium is an essential cofactor for the
binding of the substrate to the active site via Asp-49
and a highly conserved loop. The Kca values for
these enzymes are in the 0.1 to 3 mM range. The
invariant catalytic triad consists of His-48, Asp-99
and a water molecule. Seceetory PEA2 have
relatively broad substrate specificities and apparent
catalytic turnover numbers of 50 to 1 000 s -1.
Structural analysis by X-ray diffraction
(’-9 has
revealed a common three-dimensional architecture
in which five of the seven disulphide bridges are
conserved in PLA2 of types I and II, and these
structures are not noticeably altered by the binding
of substrate analogues to the active site. Although
the bee venom phospholipase A2 (type III) has a
considerably different architecture, the conforma-
tions of all the three types of PLA2 in the region
of the substrate binding site are essentially the same
and involve similar amino acid residues.
CytoplasmicPLA 2: Cytoplasmic phospholipases A2 of
higher molecular weight (40-110 kDa range) have
been reported in the cytoplasm of several cell
types. An 86 kDa protein has been cloned1’ and
the cDNA inferred amino acid sequence shows no
homology with that of the secretory PLA2. Also,
calcium and other divalent ions promote binding of
cytoplasmic PEA2 to the substrate interface through
a specific domain.
-3 The properties and substrate
specificity of these cytoplasmic PLA2 suggest that
they may be primarily involved in the mobilization
of arachidonate triggered by submicromolar con-
centrations of calcium required for the binding of
the enzyme to the interface.
Phospholipase A2 activities with very different
characteristics have been reported in a variety of
tissues, and their relationships to these two classes
of PLA2 is not yet established. Similarly, the role
and regulation of PLA2 in the inflammatory
processes is not clear. Secretory PEA2 accumulate
in certain body fluids during inflammatory
responses; however, it is not certain whether
phospholipase A2 causes inflammation or is
produced in response to inflammation. In this
review we focus on the interfacial kinetic properties
of secretory phospholipases A2, primarily because
they are well characterized. However, the kinetic
behavior of cytoplasmic PLA2 abides by the same
general principles of interfacial catalysis.
1
The kinetic paradigm
Key features of interfacial catalysis are adequately
represented by the minimal kinetic scheme shown
in Fig. 1. The theoretical basis for this scheme4,s
and its broad implications
s-2 are elaborated
elsewhere. An appreciation of this scheme is crucial
for understanding the problems encountered in
commonly used assays for activity and inhibition of
PLA2
Catalysis occurs at the interface" In interfacial catalysis it
is important to consider what the enzyme ’sees’
under a given set of experimental conditions, rather
than only considering what is present in the reaction
mixture. Although PLA). are water soluble, they
have evolved to carry out catalysis at the interface,
because in aqueous dispersions phospholipids
spontaneously organize into aggregates.
2 The
magnitude of the hydrophobic effect is so large that
the concentration of solitary, monomeric, naturally
occurring phospholipids in the aqueous phase is
very low (<100 pM). Although PLA2 obey the
Michaelis-Menten formalism, their observed kine-
tic behaviour differs from the classical kinetics of a
soluble enzyme acting on solitary monomeric
substrate in solution
22 in two major ways:4’14’23
(a) The catalytic turnover of solitary mono-
mers of short chain zwitterionic phospholipids
*1




FIG. 1. A kinetic scheme to accommodate key features of interfacial
catalysis by PLA2. The species (E*, enzyme; I, inhibitor; S, substrate; P,
products) shown in the box plane are in or bound to the bilayer, and the
enzyme in the aqueous phase is shown as E. A similar scheme can be
adopted for other lipid-water interfaces, however, in such cases the
exchange of the substrate and products must be explicitly considered.
86 Mediators of Inflammation. Vol 1992PhospholipasesA e: assay and inhibition
is often considerably slower than that on the
aqueous dispersions of long chain substrates
under optimum conditions.
(b) The composition, dispersity, organization
and dynamics of all the components at the
interface determine the overall effective rate of
catalytic turnover. Such factors determine not
only the proportion of the enzyme at the
interface but also the local concentration (mole
fraction) of the substrate and products that the
enzyme ’sees’ during the course of catalysis at
the interface.
Within the paradigm of the kinetic scheme in Fig.
1, phospholipase A2 is distributed between the
aqueous phase and the interface, and catalysis is
mediated only by the enzyme at the interface
(designated as E*). Thus the concentration of the
substrate is important in two ways: 14’15 the bulk
concentration, most conveniently expressed in units
of moles/litre, controls the fraction of the enzyme
at the interface. On the other hand, the mole
fraction of the substrate in the interface determines
the probability of the encounter of the substrate
with the enzyme at the interface, that is, it is the
concentration that the bound enzyme ’sees’ for the
formation of the Michaelis-Menten complex (E’S).
Thus the effective rate of hydrolysis is determined
not only by the number density of substrate
molecules in the interface as related to the mole
fraction of the substrate, but also by the E to E*
equilibrium that depends upon the bulk concentra-
tion of the interface.
The apparent catatic turnover is influenced by the interface"
The behaviour of amphipathic molecules in
aqueous dispersions and factors governing the
organization and dynamics of phospholipids at the
interface are now reasonably well understood.21-24
The hydrophobic effect provides the driving force
for amphipathic molecules in water to form
organized structures, such as bilayers, monolayers,
micelles and emulsions. In such aggregates, the
dynamics of exchange of monomers depends on the
shape of the amphiphile, and on the balance
between the hydrophobic and hydrophilic forces on
the amphiphile in the aqueous environment. The
free energy for the removal of long chain
phospholipid molecules from a bilayer to the
surrounding aqueous phase exceeds 20 kcal/mole.
Therefore, the concentration of solitary monomers
in the aqueous phase is well below 100 pM. Under
such conditions intervesicle exchange of phospholi-
pids has a half-time of several hours. Amphiphiles
in micelles undergo faster exchange because of
fission and fusion of micelles.
The enzyme at the interface also facilitates the
steps involved in the catalytic turnover.2s’26 In the
context of the scheme shown in Fig. 1, the apparent
activation of PLA2 at the interface is a necessary
consequence of the accessibility and availability of
the substrate to the enzyme at the interface. How
a phospholipase A2 molecule at the interface
optimizes the catalytic turnover can be operation-
ally viewed as follows.
26 Since the catalytic site of
secretory PLA2 is about 1.5 nm away from the
surface of the protein, it is likely that the bound
enzyme must dislodge the substrate monomer from
the interface to the active site without bringing the
substrate in contact with the aqueous phase. It
appears that this is achieved by desolvation of the
microinterface between the enzyme and the
interface where the substrate is localized.
25
The’controversies’: There is a general consensus on the
existence of the E to E* step as a prelude to
interfacial catalytic turnover (Fig. 1). Thus,
depending on the equilibrium and kinetic prop-
erties, this step may or may not influence the
observed steady state reaction rate. Many practical
and theoretical difficulties arise because, for a
quantitative interpretation of interfacial catalysis,
one must keep track of the fraction of the enzyme
in the interface, its residence time at the interface,
and the local concentrations of the interacting
species (substrate, products, inhibitor, calcium) that
the bound enzyme ’sees’ at the interface. Based on
such considerations, for the kinetic analysis it is
often necessary to have a detailed quantitative
knowledge of the distribution and dynamics of the
exchange of the enzyme, substrate, products, and
other additives such as surface diluents, activators
and inhibitors. Under most of the commonly used
conditions for the assay and kinetic analysis, such
variables are not controlled. Also in most published
analyses of interfacial catalysis23’27 such variables
and the constraints of the dynamics of the substrate
and products are not explicitly considered. In short,
most, if not all, of the observed anomalies in the
interfacial kinetics of PLA2 can be resolved within
the general paradigm of the scheme in Fig. 1 if
proper attention is paid to the factors regulating the
E to E* equilibrium. 14’26 Indeed, for such kinetic
analyses it is not necessary to make ad hoc
assumptions about slow ’penetration’ of the
enzyme into the interface, nor about dimerization
or acylation of PLA2 at the interface. Also it has
been experimentally demonstrated that such events
do not occur and are not required for the full
catalytic activity ofPEA2 at the interface.4,s’8’2a-3
The steady state condition at the
interface
The scheme in Fig. 1 is deceptively simple. It is
a remarkably versatile kinetic representation of
interfacial catalysis. 4’1s For example, reaction
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progress curves with virtually any shape can be
generated within the constraints of this scheme.
This is because a rigorous description of the overall
progress of the reaction requires a consideration of
not only what the enzyme ’sees’, but also how its
local environment changes with time. Such
considerations include not only the explicit terms
in the scheme, but also the implicit constraints that
control the ’local’ concentration of the substrate
and products that the enzyme ’sees’ as the reaction
progresses. In short, the organization and dynamics
of all the molecular species at the interface control
the overall effective rate of interfacial catalysis, that
is, not only the factors governing the binding of
PEA2 to the substrate interface but also the lateral
distribution and the rate of exchange of the
substrate, products and the enzyme between the
interfaces of the aggregates present in the reaction
mixture. Some of these considerations are illu-
strated by the example discussed next.
Constraints on interfacial catasis on micelles: Mixed
micelles of phospholipids and detergents have been
used extensively as substrates for PLA2 .5’27 They are
attractive in the sense that a linear initial rate of
hydrolysis is observed for several minutes. On this
basis it has been assumed that the substrate
concentration that the enzyme ’sees’ corresponds
to the total substrate in the reaction tube which
remains constant for several minutes. This may be
so, however as illustrated in Fig. 2 and elaborated
below there is no basis for such an assumption. The
major difficulties in the interpretation of the kinetics
of hydrolysis of mixed-micelles by PLA2 arise from
the fact that the rate of hydrolysis depends not only
on the nature of the enzyme and the substrate, but
also on the nature and the mole fraction of the
detergent which acts as a ’diluent’ for the substrate
and influences the surface charge density, dispersity,
and dynamics of the components. The following
kinetic and equilibrium consequences of such
factors deserve consideration"
(a) In order to compare catalytic activities of
phospholipases A2 from different sources, one
must optimize the properties of the interface
for each enzyme. In effect, it is very unlikely
that a single set of experimental conditions
using mixed micelles can be used to compare
the rates of different enzymes.
(b) It is often assumed that by increasing the
bulk mole fraction of the detergent, the
substrate is surface diluted.
27 Even after
correction for the intermicellar concentration,
this assumption would be valid only under
equilibrium conditions and only if the enzyme
can bind equally well to micelles of the
detergent as well as to the mixed micelles.
(c) For the validity of the surface dilution
under the kinetic conditions, it is also
necessary to assume that the rate of replenish-
ment of the substrate on the enzyme-
containing micelles is rapid on the time scale
of the hydrolysis of only a small proportion of
the substrate molecules in the enzyme
containing mixed-micelle, ls’19 Otherwise, the
observed steady state rate will depend on the
kinetics of phospholipid exchange between
mixed micelles.
Since such microscopic constraints for the
steady-state condition are not satisfied, it is not
possible to interpret the kinetics on mixed-micelles
according to the Michaelis-Menten formalism. For
example as shown in Fig. 2, consider what the
enzyme ’sees’ during the course of hydrolysis of
the micelle to which it is bound. The steady-state












FIG. 2. Schematic illustration of the microscopic events during the course of hydrolysis of micelles under the conditions where the enzyme
remains bound to the interface and the substrate exchanges slowly on the time scale of hydrolysis of the substrate molecules present in the
micelle. Under such conditions of ’slow replenishment’, different enzymes will be in different environments and the effective rate of hydrolysis
will be limited by the rate of replenishment.
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of a micelle, if and only if the rate of replenishment
of the substrate and the rate of removal of products
is rapid enough for only an insignificant fraction of
the substrate molecules present in the enzyme-
containing micelle to be hydrolysed. In a micelle of
aggregation number 50 that contains a bound
phospholipase A2 with kca of 300 s-l,
is hydrolysis
of ten substrate molecules would change the surface
concentration of substrate by 20% in 30 ms. Thus,
a true steady state rate in such enzyme-containing
micelles can be achieved only if the rate of
replenishment of the substrate and the rate of
removal of the product from the micelles is rapid
on the time scale of 30 ms.
There are two possible mechanisms for the
replenishment of the substrate that the bound
enzyme ’sees’. If the rate of desorption of the
enzyme from the interface is rapid on the 30 ms
time-scale, then it would leave the micelle before a
significant fraction of the substrate has been
hydrolysed. Direct measurements demonstrate that
this is not the case since the rate constant for the
desorption of the enzyme from the interface is
smaller than 0.0002 8--1,19’28 The other possibility
is that the replenishment of the substrate occurs by
the intermicellar exchange of phospholipids. For
long chain phospholipids, the intermicellar ex-
change involving passage through the aqueous
phase occurs only on the time scale of hours. The
rate of transfer of phospholipids by a collisional
process involving the fusion--fission events, occurs
on the time scale of 0.1 to 30 s depending upon the
concentration of the micelles,
31 and this is probably
the reason why the rate of hydrolysis on micelles
increases with the concentration of micelles. It is
also pertinent to note that evidence about the fast
intermicellar exchange of phospholipids in mixed
micelles should not be based on the measurements
of the exchange rate of the detergent, but rather on
the exchange rate of phospholipids from the
enzyme-containing micelles.
Based on such considerations, most observations
on the interfacial kinetics by PLA2 on mixed
micelles cannot be used to develop a detailed
description of the fundamental catalytic properties.
The crux of the problem is that the substrate is
present in micelles that have a relatively small
aggregation number and low exchange rate
compared to the catalytic turnover rate. The kinetic
analysis of any system requires a perfect mixing of
all reactants so that every enzyme, on the average,
’sees’ the same environment of substrate and
product as in the bulk concentration at any
particular time along the progress curve. In solution
enzymology, rapid mixing is normally not a concern
because the solitary monomeric reacting species
disuse in a common and uniform aqueous
environment. However, during interfacial catalysis
this is not necessarily the case, and therefore special
care has to be taken to ensure that all enzymes
operate in a common and uniform environment as
the reaction progresses.
Interfacial catalysis within explicitly defined constraints of
organization and dynamics on anionic vesicles" Our approach
for obtaining a rigorous quantitative description of
the kinetics of interfacial catalysis is based on the
premise that by studying the action of enzyme on
relatively large substrate aggregates, such as
vesicles, and by eliminating the inter-aggregate
exchange of the interacting species, it is possible to
rigorously describe the microenvironment of the
bound enzyme. As developed in this section, such
constraints on the dynamics of all the interacting
species can be accomplished on vesicles of anionic
phospholipids, where, under suitable conditions,
the exchange of the enzyme, substrate, and products
is negligible on the time scale of the entire progress
curve. 5-2’32-3s Thus as elaborated below, the
environment that the bound enzyme ’sees’ can be
rigorously described.
The molecular organization and dynamics of
phospholipids in bilayer vesicles is reasonably well
constrained (Fig. 3), which permits an unequivocal
description of interfacial catalysis under well
characterized experimental boundary conditions, is
Thus, imagine using vesicles, containing typicallly
10 000 to 200 000 phospholipid molecules, to which
a phospholipase A2 molecule binds with such high
affinity that once bound it does not leave the vesicle.
Two scenarios unfold under the conditions where
there is at most one enzyme on each enzyme-
containing vesicle. On a large vesicle, 10% of the
substrate will be hydrolysed in about one minute
by a single bound enzyme molecule. Therefore, it
is possible to satisfy the steady state reaction
condition on the microscopic level for this duration
when the mole fraction of substrate that the bound
enzyme ’sees’ would remain close to one. In
contrast, on a small vesicle containing about 5 000
phospholipids in the outer monolayer, due to a
relatively rapid decrease in the mole fraction of
substrate and accumulation of the reaction
products, only a first order reaction progress curve
is observed as the steady state concentration of E*S
and the resulting steady state rate will decrease at
each successive time point in the reaction progress
curve. Vesicle of different sizes and narrow size
dispersity can be prepared by the extrusion method.
Under such conditions each enzyme-containing
vesicle behaves identically in time and all enzymes
sample a common environment at all points during
the reaction progress,
is The system has a kind of
phase coherence, and therefore the total product
formed as a function of time is obtained by simply
adding together the contribution of products from
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Catalysis on Vesi,cles
Scooting without dissociation
Hopping through aqueous phase
E
Competitive Inhibition in the Scooting Mode
FIG. 3. (a) Schematic drawing to illustrate some key features of interfacial
catalysis on vesicles in the scooting mode where the enzyme does not
leave the interface in between the catalytic turnover cycles. Under these
conditions the bound enzyme ’sees’ only the substrate and inhibitor at
the interface to which it is bound, and the excess vesicles are not available
to the bound enzyme. In the hopping mode the enzyme desorbs from the
interface, and thus excess vesicles are ultimately accessible for the
hydrolysis. (b) Another schematic representation of PLA2 scooting on
the vesicle surface containing substrate and inhibitors.
each of the enzyme-containing vesicles. This is true
even though each enzyme molecule operates in its
own ’isolated world’ of a single vesicle. This highly
processive reaction in which the enzyme remains
bound to the vesicle during thousands of catalytic
turnover cycles is termed scooting.
If the enzyme does not bind tightly to the vesicle
it may hop from one vesicle to another during the
reaction. Such hopping must be eliminated since the
kinetic results under these conditions cannot be
readily interpreted. For example, after the initiation
of the reaction, an enzyme may leave a partially
hydrolysed vesicle and bind to a vesicle that has not
’seen’ enzyme previously. Alternatively, another
enzyme may leave a vesicle shortly after binding to
it and bind to a vesicle that has been completely
hydrolysed. Clearly, hopping among vesicles gives
a scrambling of the time of reaction and invalidates
the kinetic analysis. Even if the hopping occurs
rapidly, under such conditions one must take into
consideration the contribution of the ’on’ and ’off’
steps for the enzyme to and from the interface in
the catalytic turnover cycle,14’1s which may not
necessarily be once per catalytic cycle.
Other attractive features of interfacial catalysis in
the scooting mode may also be noted.
(a) The E to E* equilibrium is completely in
favour of E*,
14 and the hydrolysis starts
immediately after the addition of PLA2 .32
(b) The binding isotherms of PLA2 to vesicles
are quantitatively interpreted in terms of the
E + nL to E* equilibrium,26’3’6 where
binding of one enzyme molecule to the
interface requires n lipid molecules.
(c) Binding of PLA2 to the bilayer interface
does not require occupancy of the active site
of the enzyme by a substrate, inhibitor or
calcium, which establishes that the binding of
the enzyme to the interface and the catalytic
cycle are separate steps. 1<18’26
(d) Over 30 different PLA2 from a variety of
sources also exhibit catalysis in the scooting
mode not only on DMPM vesicles
8 but also
on covesicles of zwitterionic and anionic
phospholipids.
7 This suggests that a highly
processive catalytic turnover at the interface is
a general property of anionic interfaces.
(e) The gross organization of the bilayer is not
altered on binding of PLA2 to the outer
monolayer of anionic phospholipid vesi-
cles.14,15
(f) In bilayers, the reaction sequence in the
aqueous phase is neglected because the
concentration of solitary substrate molecules
in the aqueous phase is exceedingly small
(< 100 pM) compared to the apparent affinity
of the enzyme for the monomeric substrate.
(g) The half-time for transbilayer movement
(flip-flop) of phospholipids is of the order of
several hours.2
(h) The intervesicle exchange of the substrate
and the products is negligible on the time scale
usually employed for the kinetic studies.24’3
(i) The rate of lateral diffusion of phospholi-
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pids in vesicles is at least ten times faster than
14 the rate of catalytic turnover.
(i) The integrity of the vesicles is maintained
because under suitably chosen conditions the
rate of fusion of vesicles is negligibly small.
32
In addition, the products of hydrolysis of long
chain phospholipids also form bilayers.
37 Thus, the
integrity of the substrate bilayer is maintained even
when all the substrate molecules in the outer
monolayer of the target vesicles are hydrolysed, and
contents of the inner aqueous compartment of
vesicles are not released even when the bilayer
surface is substantially covered by PLA2 .15
These observations demonstrate that not only is
the bilayer organization retained during and after
the hydrolysis of vesicles by PLA2, but within the
constraints of the organization and dynamics of
phospholipids in bilayer vesicles it is possible to
rigorously describe the kinetics of interfacial
catalysis in the scooting mode on anionic
vesicles, the steady state initial rate of hydrolysis is
observed for several minutes under these condi-
tions.
32 Similarly, by a yet unknown mechanism,
the contribution of the parallel kinetic processes
without compromising the underlying catalytic
mechanism for the enzyme.
Lipid transfer between vesicles: Owing to the finite size
of vesicles, in the absence of intervesicle exchange
of phospholipids, the initial steady state rate in the
largest vesicles can be maintained only for about a
minute. It can however be extended by promoting
intervesicle transfer of phospholipids as accom-
plished in two different ways for DMPM vesicles.
At calcium concentrations greater than 1.5 mM, the
half-time for fusion of DMPM vesicles is of the
order of a few seconds. Thus, even with small
vesicles, the steady state initial rate of hydrolysis is
observed for several minutes under these condi-
tions.
32 Similarly, by a yet unknown mechanism,
polymyxin B increases the rate of intervesicle
transfer of DMPM molecules, such that in the
presence of 1/M polymyxin B, the steady state
initial rate of hydrolysis is observed for several
minutes.
19 The initial enzymatic rate observed under
these conditions corresponds to the steady-state rate
at mole fraction 1 of the substrate at the interface.
As described later such conditions are very useful
for kinetic characterization of PLA2 activity and
inhibition because all the enzyme remains at the
interface.
Hydro&sis of zwitterionic vesicles: Compared to anionic
vesicles, the affinity of most PLA2 for zwitterionic
vesicles is poor, and it increases in the presence of
anionic additives. For example the dissociation
constant, Kd, for pig pancreatic PLA2 from DTPC
vesicles is > 10 mM, more than 10-fold larger than
the dissociation constant from DTPM or DMPM
vesicles (Kd < 1 pM). This difference is apparent in
reaction progress curves for the hydrolysis of
DMPC vesicles4 where a lag period is observed.
The duration of the lag depends on the presence of
lipophilic additives and on the gel-fluid transition
properties of the bilayer. The lag is shortest and the
percentage hydrolysis at a single time point is
highest (apparent activation) at the gel-fluid phase
transition temperature of phosphatidylcholine bi-
layers. Such a lag is not observed in phosphati-
dylcholine vesicles that contain the products of
hydrolysis or other anionic amphiphiles. This is due
to an increase in the fraction of the bound
enzyme. 36’38 Also the K for E* on DTPC vesicles
remains the same (> 10 mM) either at, below, or
above the phase transition temperature.3<39 Thus
the shape of the entire progress curve, including
the lag period and the apparent activation, can be
quantitatively accounted for in terms of the
product-dependent shift in the E to E* equilib-
rium.4 As fatty acid molecules are formed, the
vesicles take on an anionic character and this causes
an increase in the fraction of vesicle-bound enzyme
with a concomitant increase in the reaction velocity.
Even in the presence of the products of hydrolysis
the K on the ternary vesicles is of the order of
0.1 mM. Therefore the bound enzyme hops
between vesicles. As discussed earlier, under these
conditions the ’on’ and the ’off’ steps contribute to
the catalytic turnover period. Such anomalous
kinetics observed with zwitterionic vesicles makes
them rather unsuitable for assay of PLA2 activity
and inhibition.
Uses of interfacial catasis in the scooting mode: The unique
features of catalysis in the scooting mode on anionic
vesicles permit quantitative characterization of
virtually all aspects of interfacial catalysis. Such
studies with DMPM vesicles have unequivocally
demonstrated that secretory PLA2 from virtually all
sources are fully catalytically active as monomers.
In addition, the entire reaction progress curve has
been characterized to obtain values of the interfacial
rate and equilibrium parameters for the pancreatic
PLA2 .5 This provides a basis for evaluating
substrate specificity,
17 specific competitive in-
hibitors,<2’3s’4 effect of activators such as
polymyxin B
19 and calcium,
1 and the kinetics of
covalently modified enzymes.<8’37
Through such studies, it has also been
demonstrated that the effects of many previously
reported phospholipase A2 inhibitors are due to a
shift in the E to E* equilibrium toward the enzyme
in the aqueous phase.<41 Similarly, the anomalous
kinetics at the gel-fluid transition or at isothermal
phase transition in zwitterionic bilayer is due to a
shift in the E to E* equilibrium. 14’33’3--39 These
observations demonstrate that even though the
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organization and dynamics of the amphiphiles in
the interface has a profound influence on the E to
E* equilibrium, the primary catalytic parameters for
the turnover in the interface are virtually insensitive
to the nonspecific organizational perturbations.
Through such protocols that unequivocally distin-
guish the kinetic contribution of the E to E* step
from the steps involved in the catalytic turnover
cycle, it should be possible to carry out a variety of
structure-activity correlations not only with sub-
strates and inhibitors, but also with site-directed
mutants designed in an effort to understand the role
of specific amino acid residues in the catalytic and
interfacial events.
Assay of phospholipase Az activity
and inhibition in the scooting mode
The major problems encountered in the assay of
phospholipase A2 activity are due to the inability to
control the E to E* equilibrium. To some extent
this equilibrium depends on the organization and
dynamics of the interface, therefore activities of
enzymes from different sources cannot be compared
readily on certain interfaces. Also the presence of
lipophilic impurities can shift the E to E*
equilibrium and thus modulate the apparent
activity. This difficulty can be minimized to a
certain extent by using sufficiently high bulk
substrate concentrations so that all the enzyme
molecules are bound to the interface. However, at
interfaces containing zwitterionic phospholipids the
apparent Kd for PLA2 is often in the millimolar
range. Thus, the problem becomes particularly
acute with radiolabelled or fluorescently labelled
substrates which are used typically in the
submicromolar concentration range. Under such
conditions only a fraction of the total enzyme is
bound, and this fraction could change significantly
in the presence of impurities. 16’4’41 Many phospholi-
pase a2 assays suffer from this problem, although
with proper considerations the micelle-based assays
have been used to identify relatively potent specific
inhibitors of PLA2 .42 In addition, a major problem
with such assays for PLA2 inhibitors is that not only
do they give false-positives
16 but as elaborated
earlier in this article, with such assays it is virtually
impossible to obtain the primary kinetic and
inhibition parameters which have well established
mechanistic significance.s
The difficulties mentioned above can be resolved
almost completely by using substrates with anionic
head groups. Radiometric, fluorescence or absor-
bance based assays using appropriately labelled
anionic and zwitterionic phospholipids have been
reported.
4s-4 Such assays permit the continuous
measurement of PLA2 activity in as little as 5 #1 of
crude blood plasma, corresponding to a few
92 Mediators of Inflammation. Vol 1992
picograms of pancreatic or snake venom enzyme.
However, adoption of such assays for inhibition
studies requires proper consideration of the
background quenching by the test solutes, and the
various binding, partitioning and solubility equi-
libria. Similarly, the assay system consisting of
radiolabelled "autoclaved Escherichia coli" has never
been fully characterized. These dispersions contain
a relatively high mole fraction of anionic
phospholipids such as cardiolipin and phosphatidyl-
ethanolamines. However, only a relatively small
amount of the substrate (submicromolar range) is
used for the assay of the PLA2 inhibition, which
creates difficulties as it gives false-positives due to
a solute-dependent shift in the E to E* equilibrium.
Virtually all the problems associated with the
assay of PLA2 activity and specific inhibition are
obviated by the use of DMPM vesicles under
constant pH conditions,15-2’4’47 where PLA2
activity from virtually all sources and their mutants
can be assayed under identical conditions on the
same interface in the absence of additives. Since the
Kd for E* on DMPM vesicles is in the picomolar
range, the bulk substrate concentrations in the
micromolar range are adequate to ensure that all
the enzyme remains at the interface, and yet there
is sufficient substrate available to the bound enzyme
to allow hydrolysis to proceed for several minutes
under steady state conditions. Such small bulk
concentrations of substrate also ensure that the
inevitable background from the probes remains
low. On such anionic interfaces, lipophilic impur-
ities have little effect on the E to E* equilibrium,
therefore the activity is not perturbed by
nonspecific additives incorporated up to 0.2 mole
fraction in the interface. This is a particularly
important consideration because the mole fraction
of an additive in the interface depends not only on
its absolute concentration but also on its bilayer/-
water partition coefficient. For example, with a
substrate concentration of 1/aM, only a 0.4/M
concentration of a hydrophobic additive would be
sufficient to bring the interface mole fraction to 0.3.
Such problems are minimized in the pH-stat
titration assay where the bulk concentration of
substrate can be 1 mM without significant back-
ground rates. As discussed in the next section, this
assay can be used for quantitative and mechanistic
characterization of specific competitive inhibitors
without any false-positives.
Other distinct advantages of protocols for
catalysis in the scooting mode include:
(a) The same assay can be used for
18 phospholipase A2 from virtually all sources.
(b) It can be used to establish the presence of
a low abundance PEA2 impurity.
28
(c) Based on the same general principle, the
effects of lipophilic impurities on the E to E*PhospholipasesA e" assay and inhibition
equilibrium, if any, can be directly monitored
by determining the extent of hydrolysis per
enzyme.15,32,
47
(d) Effects associated with the partitioning of
inhibitors can also be discerned by catalysis in
the scooting mode.4 Since the aflqnity of
secretory PLA2 for anionic vesicles is very
large, dilution of the reaction mixture would
influence the rate of hydrolysis only if the




Criteria for competitive inhibition: Within the con-
straints of the organization and dynamics of the
bilayer, interfacial catalysis in the scooting mode
can be adopted to obtain quantitative information
about the whole Michaelis-Menten space, including
the characterization of competitive inhibitors. 14,1s
The primary considerations and the basic protocols
are outlined below.
Rates of hydrolysis" The ratio of the initial rates of
hydrolysis in the scooting mode in the absence (Vo)
and in the presence (v) of a competitive inhibitor





the ratio of the turnover numbers
under the first-order kinetic conditions (NskD in the
presence and in the absence of a competitive
inhibitor at mole fraction X* is given by"
(Nski)o 1 + 1 X* (Sski)I
(2)
Here Ns is the number of substrate molecules
on the outer monolayer of the vesicles (related to
the vesicle size), and ki is the first-order relaxation
constant for the hydrolysis of the N molecules.
14
The terms K, K* and K expressed as mole
fractions have their usual meaning in the context of
the Michaelis-Menten formalism adopted for
catalytic turnover at the interface. The validity of
these relations has been elaborated
5 and exper-
imentally demonstrated elsewhere. However,
intuitively it makes sense that under initial velocity
conditions in large vesicles where the mole fraction
of substrate is close to one, the inhibitor competes
with the substrate and thus the ratio of velocities
depends on the relative magnitudes of the K for
the substrate and the KI* values for inhibitors
(equation 1). With small vesicles under the
first-order kinetic conditions, the mole fraction of
the products increases rapidly, and the relative rate
equation contains theK for products as well as the
K’ since the inhibitor competes with the product
for the binding to the enzyme (equation 2).
Based on these relationships a plot of Vo/V
versus X*/(1 XI*) is linear (cf. Dixon plot), with a
y-intercept of one, and the value of XI(50), the mole
fraction of the inhibitor for 50% inhibition is
obtained from the slope. For a series of inhibitors,
the XI(50) values are related to K*. The value of
K or K can be calculated if one or the other
term is obtained independently.
6 Similarly, from
the effect of an inhibitor on the first order curve it
is possible to obtain hi(50), the mole fraction for
50% decrease in the value of Nski. For the action
of pig pancreatic phospholipase A2 on DMPM
vesicles, Ka=0.35 mole fraction and K3
0.025 mole fraction.
6 The value of Ka is in the
same range as the concentration of the substrate in
the interface. Therefore, a potent inhibitor like
MJ33, KI* 0.0008 mole fraction2 would have
a significant inhibitory effect even if one inhibitor
molecule is present per 1 000 substrate molecules in
the interface.
Kinetic prooffor competitive inhibition" The ratio
1+ 1
(Ss/i)o /vl XI(50)
V 1 1 (3)
is particularly diagnostic because it provides a
kinetic proof for the competitive nature of the
inhibition of interfacial catalysis in the scooting
mode. The (Nski)o/Vo ratio can also be obtained by
independent kinetic methods; either from the
analysis of the whole progress curve,
6 or from the
Ka and Ke* values determined independently.
2
Concentration dependence: The concentration depen-
dence of an inhibitor is always viewed in the context
of the substrate interface. For a very hydrophobic
inhibitor which partitions essentially completely in
the interface, the X’ value can be calculated on
the basis of the bulk inhibitor and substrate
concentration as [I]/([I] 4-[S]). For inhibitors
which are poorly partitioned it is necessary to
consider the fraction of the inhibitor that is in the
interface. Although partition coeflqcients can be
determined independently, the effect of such factors
can be qualitatively judged on the basis of
experiments in which the dilution of the reaction
mixture has a significant increase in the effective
XI(50) values if the inhibitor is poorly partitioned
Mediators of Inflammation. Vol 1992 93M. K. Jain et al.
in the bilayer (see also later). Since the E to E*
equilibrium is not noticeably influenced under these
conditions, such dilution experiments can be
quantitatively interpreted to obtain the values of the
partition coefficient and true XI(50) values.
Tight binding phospholipid analogues: So far two classes
of potent inhibitors of PLA2 have been identified
(Fig. 4). In molecules like MG14 or MJ33 there is
a phosphonate or a phosphate group which
presumably resembles the tetrahedral transition
state formed during the hydrolysis of the ester bond
in the sn-2-position.2’4 The X-ray structure of
MG14 bound to PLA2 reveals a coordination of one
of the phosphonate oxyanions to the calcium, and
the other oxygen to a protonated imidazole ring of
the active site histidine. In addition one of the
sn-3-phosphate oxygens of MG14 is also bound to
the calcium. Replacement of the sn-2 ester linkage
by an amide also gives quite potent inhibitors,2’42
and the oxygens on the sn-2- P--O or C---O
groups are coordinated directly to calcium at the
active site. 7 Similarly, the P--O- of the sn-2-
phosphate interacts with the cationic charge on the
protonated histidine.
6 Binding of these inhibitors
requires the presence of calcium, although barium
does not support such binding.
2
These interactions at the active site are consistent
with the X-ray crystallographic results on the
co-crystals<7’9 which also demonstrate that the
sn-3-phosphate is liganded to the calcium ion and
is also hydrogen-bonded to Tyr-69. However, such
an interaction may not contribute to the stability of
the complex because the K* values for inhibitors
like MJ33, which do not have a sn-3-phosphate
group, are in fact somewhat smaller than those for
inhibitors containing the sn-3-phosphate.
2 In
addition, the N--H of the amide forms a
hydrogen-bond with the imidazole N--H of
His-48. Thus, opposite effects of pH are predicted
and observed44: KI* for amides decreases at higher
pH, whereas the KI* for the sn-2-phosphates or
phosphonates increases at lower pH.
Lipophilic solutes: Lipophilic solutes have a variety of
effects on the integrity of vesicles. Such effects can
be unambiguously discerned by monitoring the
scooting kinetics under the first order conditions.
Here, any significant effect on the size of vesicles
obtained from the first order progress curve would
be a caution flag against its efficacy as a PLA2
inhibitor. As summarized in Table 1 many of the
inhibitors reported in the literature have been
shown
16 to be nonspecific because they reduce the
rate of hydrolysis by promoting the desorption of
the bound enzyme.
With the criteria summarized in this section a
broad range of specific competitive inhibitors of
PLA2 have been kinetically characterized2’32’4 and
these can be unequivocally distinguished from other
nonspecific inhibitors. 1<38’48 Many of the competi-
tive inhibitors identified so far are effective at
<0.001 mole fraction in the interface, they are
























FIG. 4. Structures of four potent competitive inhibitors of PLA2: MJ33, RM-2, H-18, and MG-14 with K values 0.0008, 0.0028, 0.0016 and
0.001 mole fractions, respectively, for pig pancreatic phospholipase A2. See reference 18 for details.
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micelles), and they partition readily and essentially
completely into the bilayer. Since these inhibitors
probably do not cross the cell membrane, they have
had little use as pharmacological agents. However,
recently we have successfully delivered MJ33 in
intact lung by taking advantage of the fact that the
liposomes containing inhibitors are taken up by
intact cells. MJ33 delivered in this fashion had no
effect on the arachidonate cascade, although it
selectively blocked the secretory PLA2 activated
during ischaemia.
49
Independent methods to measure K*: Besides the kinetic
methods described above, two other independent
methods have been used to quantitatively character-
ize the binding of inhibitors to the active sites of
PLA2.
Use of ligands: The rate of chemical modification of
histidine-48 in the catalytic site of secretory PLA2
by an alkylating agent is modulated in the presence
of ligands that bind to the catalytic site.
16 Such
ligands include calcium, specific inhibitors, PLA2
reaction products, and substrate analogues. The
kinetics of alkylation of phospholipase A2 bound to
a neutral diluent, such as 2-hexadecylglycerophos-
phocholine, is not modulated because such
amphiphiles have poor affinity for the catalytic site.
Thus, from the relative rates of alkylation of the
enzyme bound to a neutral diluent in the absence
and in the presence of a suitable ligand, it is possible
to obtain the values of Kca, K*, K,, and K,
respectively.
Spectroscopic methods: Under suitable conditions,
binding of a ligand to phospholipase a2 present at
the interface of a neutral diluent produces
perturbations in the UV and fluorescence emission
spectral properties of the enzyme. For example,
when pig or bovine pancreatic PLA2 bound to the
interface of a neutral diluent is titrated with an
increasing mole fraction of an inhibitor, characteris-
tic UV spectral changes are observed in the
280-300 nm region. Such titration curves can be
used to obtain KI* values, which are identical to
those obtained by the protection from alkylation
method.
Inhibition of the hydrosis of water-soluble monomeric
substrates: Short chain zwitterionic phospholipids
below their critical micelle concentrations are also
hydrolysed by PLA2, and the hydrolysis is inhibited




it is possible to obtain values of *’Ikin (the KI
for the inhibition determined in kinetic studies) and
KM from the dependence of I(50) on [S]. The *’IRkin
values obtained under these kinetic conditions are
always significantly smaller than the dissociation
constant for the enzyme inhibitor complex in the
aqueous phase. However the K
kin values are
similar to the values of the effective dissociation
constants obtained for the enzyme at the interface
of a neutral diluent.
51 These results show that even
if the substrate molecules are dispersed as solitary
monomers, during the course of their hydrolysis the
pig pancreatic phospholipase A2 is in a state that
resembles the enzyme bound to the interface. One
of the ways in which this could happen is that
binding of a substrate molecule to the active site
promotes (nucleates) aggregation of additional
substrate molecules so as to achieve appropriate
hydrophil--liphophil balance. Thus the ES com-
plex is stabilized as a larger aggregate with
additional amphiphiles present in the medium.
Binding to the interface versus binding to the active site:
Micelles of alkylphosphocholines have been used as
amphiphile models in physical studies of bound
PLA2. Protection from alkylation studies show that
these amphiphiles have a modest affinity ,or the
active site, K* 0.65 mole fraction.
18 Two
processes must be considered. The bulk concentra-
tion of the amphiphile modulates the fraction of the
enzyme bound to micelles (E*). Since the mole
fraction of the amphiphile at the interface is always
one, about 60% of the enzyme would be in the E*I
form and 40% in the E* form in the presence of an
excess of bulk amphiphile. Thus virtually all such
results on the physical studies at saturating bulk
concentrations of the amphiphile contain informa-




As discussed in this review, analysis of inhibitors
of PLA2 in the scooting mode eliminates the kinetic
complications due to the perturbation of the E to
E* step. This analysis is not designed to detect
inhibitors that bind to the interfacial recognition
site of PLA2 in the aqueous phase and prevent its
association with the substrate interface. This is
because the affinity of the enzyme toward anionic
interfaces is very large and therefore the concentra-
tion of the enzyme in the aqueous phase is
insignificant. Under pharmacological conditions it
is conceivable that this may not be the case. General
consequences of the possible equilibria at the
interface under such conditions are elaborated
below.
In principle, a phospholipase a2 inhibitor could
interact either in the membrane phase with E* or
in the aqueous phase with E. Thus, in order to
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develop an optimal strategy to search for specific
active site-directed inhibitors of PLA2, it is useful to
consider a general scheme in which all species
partition between the water and membrane phases.
In order to identify inhibitors that are likely to
function in vivo, it is also necessary to consider the
factors that apply in the screen versus in man. The
minimal scheme in Fig. 5 takes into consideration
all the necessary interactions. The equilibrium










It is useful to appreciate the key considerations
underlying these definitions:
(a) The concentration terms (in the square
brackets) with the w subscript designate the
moles of the indicated species per volume of
water phase, Vw. The asterisks denote species
that are bound to the interface of the amphiphile
phase A. For example, A* designates the moles
of amphiphile A that are at the interface and
therefore available for enzyme binding, and in
general A* will be smaller than the total moles
of A in the system, AT. For example, in the
screen, only the amphiphile molecules in the
outer layer of the vesicles (about 50%) can
interact with the enzyme. In man, it is likely
that A*/AT will be even smaller because only
a small fraction of the total A phase is exposed
to the enzyme. XI* designates the mole fraction
of inhibitor in the totalA phase if the inhibitor
can partition into the total A phase. Since the
amount of A is typically in large excess over
the amount of inhibitor in the A phase, Ia, it
usually holds that Xi* IA/AT.
(b) K and K denote the dissociation
constants for the enzyme-inhibitor interac-
tions in the water phase and A phase,
respectively. Kd and K denote the equilib-
rium constants for the dissociation of either
E* or E*I from the interface (A* phase).
(c) K’ is the concentration of the amphiphile
at which half of the inhibitor is bound to the
amphiphile interface. It is related to the
standard partition coefficient for the inhibitor,
P (IA/VA)/[I]w by the relationship fwK’/
[A]T (Vw/VA)/PI I/Ig. Here VA is the
volume of the total A phase, fw is the fraction
of total system volume, V T, that is the
aqueous, and
(d) The last definition is a thermodynamic
relationship that follows from the definitions
of the equilibrium constants. Also note that
the unit of KI* is mole fraction, the unit of
KI, Kd and K is moles/1.
Using the above definitions, an expression for the
effective dissociation constant for the enzyme--















E* + 1" E*I
KI,
FIG. 5. Interaction scheme to illustrate the partitioning of all enzyme (E)
and inhibitor (I) species between the aqueous and membrane phase
consisting of the amphiphile (A). The equilibrium dissociation constant
of the bound enzyme and the enzyme inhibitor complex from the interface
is given by Kd and /d, respectively. Similarly, the equilibrium
dissociation constants for the inhibitor from the enzyme in the aqueous
phase and in the interface are given by K and K’, respectively. The
distribution coefficient for the inhibitor between the aqueous phase and
the interface is given by K’, i.e., the concentration of the interface at
which half of the inhibitor is in the interface. See text for details.
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To develop a ’feel’ for the interpretation and
application of this general equation it is useful
to imagine an inhibitor that has a portion that
interacts with the active site of the enzyme and
another portion that extends away from the enzyme
and only interacts with the environment. The first
requirement for the design of a potent inhibitor
must be to provide maximal interactions in the
active site. This part of the inhibitor structure will
influence primarily the values of KI* and K.
Changes in the remaining portion, however, will
have little or no effect on these constants but can
influence the efficiency of the inhibitor by
changing the partitioning of I and E1 between the
water and amphiphile (A) phases. It is reasonable
to suggest that such changes will affect K’ and K
by the same factor, ft. If we compare two inhibitorsPhospholipasesA e: assay and inhibition
Table 1. Compounds that had no effect at mole fraction 0.1 on
the alkylation and on interfacial catalysis in the scooting mode
(Adopted from reference 16)
Alkanols (C6 to C14 including cis and trans tetradec-9-enol)
Fatty acids (C8 to C2o including 18:1, 18:2, 18:3 and 20:4),
7,7-dimethyl-eicosadienoic acid, and long chain phenols
Local anaesthetics (dibucaine, tetracaine, procaine, benzocaine)
Antimalarials (mepacrine and quinacrine)
Ketamine, halothane, chloroform, carbon tetrachloride, EMD
21657
Manoalog*, gossypol*, alkylating agents
Indomethacin, cortisone and related antiinflammatory agents,
alphaxalone, flufenamic acid, phenothiazines
Aristolochic acid, plastatin, lipocortin
Butyrophenone (U10029A)
Alkylammonium salts (Clo to C8), spermine, putrescine,
polymyxin B
Antibiotics (gentamycin, tobramycin, streptomycin)
* A covalent modifier
that have similar active--site interactions but differ
in their structures outside of the enzyme, which is
going to be the most efficient in the screen and in
man? If we replace K’ and K in the equation 5
by ilK’ and flK and seek the smallest value ofK
ff
as a function of/3, two extreme values are found
for either very large or very small/3.
For small flfwK’/[A]T and/3K/[a*]w:
+ a/Ysm, [a.]
KldgI ( gd) KdK’
[A]T 1 + (Ta)
[A*]w
The expression on the right is obtained by
replacing K* with the equivalent collection of
constants according to equation 5.
For large flfwK’/[a]w and flK/[A*]w:
Keff, fwK*[a*]w 1 + (Tb) ]fllarge-- Kd [A*]w
Small fifwK’/[A]w implies that IA > I and small
flKI /[A*I  implies that E*I > El.
The ratio of the values of K
ff for small and
large/3 is given by equation 8.
K’e’ (EI) ]small K -
(8)
Jfllarge (Kth*) I
Here, fA* is the fraction of A that is at the
interface, fa, A*/Aw. When the ratio in equa-
tion 8 is less than one, this implies that the case of
small / leads to a smaller value of K
ff and
therefore the best inhibitor will be the one with the
smallest K and that partitions mostly into
the A phase. Conversely, when this ratio is larger
than one, the best inhibitor will be the one with
the lowest K* (also the lowest K since the change
described by /g does not involve direct en-
zyme-inhibitor interactions) and that partitions
mostly into the aqueous phase. In other words,
equation 8 expresses the relative partitioning
between the two phases of the enzyme--inhibitor
complex and the inhibitor alone, and the phase in
which the inhibitor functions most efficiently
depends on this ratio.
The ratio in equation 8 is hard to predict and its
value will vary from inhibitor to inhibitor. On
the one hand, the partitioning of EI into the
interface relative to I alone is favoured by the fact
that the E1 complex can interact with the interface
using both the regions of I that protrude from
the enzyme (effected by /3) and the interfacial
binding surface of the enzyme. On the other hand,
the partitioning of I into the membrane is favoured
over EI by two factors. Firstly, the portion
of I that is within the confines of the enzyme will
help I, but not EI, to partition into the interface.
Secondly, the possible advantage of EI partitioning
over I will be reduced by the fact that in man
the value of fa* is expected to be significantly
smaller than in the screen.
The ratio given in equation 8 will in general have
a different value for every inhibitor and furthermore
there is no a priori way to predict the value of this
ratio. Thus, it is not a general solution to the
problem of deciding whether to inhibit the
PLA2 in the aqueous phase versus the membrane
phase. Based on the following arguments, it is
probably best to use a screen in which the
phospholipase a2 is operating in the scooting mode.
Firstly, in order to search for inhibitors that act in
the aqueous phase, it is necessary to use an
assay in which the enzyme is not tightly bound to
the interface. However, as discussed previously
there is precedence demonstrating that such an
assay will pick up compounds that function as
nonspecific modulators of the E to E* equilib-
rium.
16 Secondly, it is difficult to predict a priori
whether an inhibitor that binds to E will function
in vivo. This is because the degree of inhibition
will depend not only on the K] value but also on
the affinity of the PLA2 for the various inter-
faces that exist in vivo, and the magnitude of such
affinities is not yet known. The scooting mode
analysis detects inhibitors that have a low value of
K* and such compounds would almost certainly
work in man. This is because regardless of where
the enzyme is located most of the time in vivo, it
must go to the interface for the lipolysis reac-
tion.
In the scooting mode analysis, E* >> E, and it
is also very likely that E*I >> EI since the binding
of the enzyme to anionic interfaces occurs with high
affinity. With these inequalities, equation 6 can be
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simplified to give equation 9.
K
ff KI*[A]T 1 -b K*[A]: 1 + (9)
In man, the term I/IA is expected to be smaller
than one for most compounds based on the
following argument. The value of Pz for most
organic compounds is larger than 100. In man,
VA and Vw are within a factor of ten of each other,
and so it is expected that Ia > I for most inhibitors
and equation 9 can be simplified to give equation
10.
(ff)Man K, [A]TMan (10)
In contrast, in typical PLA2 inhibitor screens,
the substrate concentration is in the range of
10-100 #M so that Vw will be about 104-10S-fold
larger than VA and thus I > IA may hold in many
cases. In this case, equation 9 can be simplified to
give equation 11.
/ i \Sceen
Screen|__| (Kff)Screen K*[A]T \IA]
K,[a]creen
1 //gw\screen %-) (11)
The same K has been used in both equations
10 and 11, since this dissociation constant is likely
to be the same in both the screen and in man. Also,
as indicated in these equations, the value of [A]T is
different in the two systems, but this will not
influence the search for inhibitors since this will
introduce the same difference for all inhibitors. It
is clear from these equations that structural
modifications to the inhibitor that produce a lower
value of K will also lead to a decrease in K
ff
and such changes will improve the degree of
inhibition in both the screen and in man.
What are the consequences of the fact that I/IA
is much larger in the screen than in man? Since in
the scooting mode PLA2 are confined to the
interface, it is the value of X* and its relationship
to K* that will determine the fraction of enzyme
that is inhibited (equation 1). If the screen is
conducted with [A]
creen-- 10-Sm and [I]r
creen--
10-SM, and if P is 10
3 the value of X*
in the screen will be approximately 10 -s. In man,
if we use [I] 10-SM and the same P 10
as in the screen, then since [A] is about 0.3 M,
X* in man will be about 3 10-. Thus, it is
clear from this calculation that despite the relatively
large value of I/IA in the screen, X* in the screen
will be large enough so that the inhibition will not
be missed. It is also important to note that an
inhibitor that functions well in the screen will likely
function equally well or even better in man, since
a larger fraction of Iv will be in the membrane phase
in man. There is one possible exception to this
generalization. In man an inhibitor could be
substantially partitioned into interfaces that are not
available to the enzyme, i.e. fA* is very small.
Under these conditions K
ff would increase.
The main consequence of the large value of I/IA
in the screen is that K
ff is a function of both K
and P (equation 10), whereas K
ff in man is almost
always independent of PI (equation 11). Thus, if
structural changes are made to the inhibitor that
change the value of K
f in the screen (and thus
the degree of inhibition), it will not be immediately
obvious whether the increase in potency is due to
changes in P, K, or both. A simple solution to
this problem is to re-run the in vitro analysis using
a five- to ten-fold higher value of [[A-IscreenxlT If K
ff
changes in proportion to [A] (equation 11),
then the change in inhibitor potency is mainly due
to a change in K/*. However, if the effect is due only
to a change in PI, then equation 11 applies, and
since [A]x and VA change by the same factor, the
observed K
ff will not change when [A]w is
increased.
In summary, by using the scooting assay to
search for PLA2 inhibitors, water soluble com-
pounds that bind to E and prevent its interracial
binding probably will not be found. However, it is
hard to imagine a screen that would find such
compounds without the interference from numer-
ous nonspecific agents that modulate the E to E*
equilibrium. Furthermore, the scooting analysis
yields the value of KI* and inhibitors with
sufficiently small values of this dissociation constant
are guaranteed to function in vivo. The only problem
that arises in translating the effectiveness of the
inhibitor from in vitro system to the in vivo system
is due to partitioning effects; however, this problem
is readily remedied as discussed above.
Epilogue
Interfacial enzymology involves the interplay of
physical and interfacial processes with biochemical
catalysis. Such enzymes must access the substrate at
the interface because the concentration of solitary
monomeric substrate molecules in the aqueous
phase is very low, and also the rate of substrate
desorption from the interface to the aqueous phase
is very low. The microinterface between the bound
enzyme and the organized substrate not only
facilitates formation of the enzyme-substrate
complex, but the residence time of the enzyme at
the interface controls the extent of processivity at
the interface. The minimum kinetic model shown
in Fig. 1 permits adaptation of the Michaelis-
Menten formalism as a basis to accommodate
virtually all aspects of interfacial catalysis. The
binding of the enzyme to the interface has two
extreme kinetic consequences (Fig. 3): during
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catalysis in the scooting mode, binding of the
enzyme to the interface influences only the
pre-steady state portion of the progress curve; on
the other hand, catalysis in which the enzyme hops
among the ensemble of vesicles, the E to E* step,
becomes a part of each catalytic cycle in the
steady-state. Complex kinetic consequences with
different extents of processivity are predicted14’26 if
the enzyme hops after a few catalytic turnovers. The
intervesicle exchange of the enzyme, substrate and
products creates further time-dependent changes in
what the enzyme ’sees’ during the progress of the
reaction. In the absence of such parallel rate
processes, as is the case in the scooting mode, the
kinetics of interfacial catalysis is considerably
simplified.
15-2
The kinetic studies on the characterization of
specific competitive inhibitors of PLA2 have also
come of age. Kinetic analysis of PLA2 in the
scooting mode provides a reliable method for
random screening of large compound banks in
order to find novel lead compounds. It is also
possible to obtain very potent inhibitors and to
determine their interracial K values by using
three independent methods. With the help of the
inhibitors available so far, it is now possible to
address detailed mechanistic questions about the
catalytic steps and the nature of the transition state,
and to begin to ask questions related to the
biological role of phospholipases A2.
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